Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

QNRXQNRX
7 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in QUOIN PHARMACEUTICALS LTD

CITADEL ADVISORS LLC holds 32,519 shares of QNRX (QUOIN PHARMACEUTICALS LTD), worth $214,625 as of 2026-Q1. This is a new position.

Current Value

$214,625

Current Shares

32,519

Total Value Change

+$205,625

Total Shares Change

+12,937

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
32,519
-
$214,6250.0%$8.74
35
2024-Q2
Exited
0
-100.0%
$00.0%$20.30
0
2024-Q1
New
10,786
-
$10,2260.0%$33.25
26
2023-Q1
Exited
0
-100.0%
$00.0%$205.80
0
2022-Q4
Decreased
10,657
-39.5%
$15,1330.0%$596.40
0
2022-Q3
Decreased
17,614
-10.1%
$39,0000.0%$1,033.20
0
2022-Q2
New
19,582
-
$9,0000.0%$2,630.25
26

Other major holders of QNRX: Woodline Partners LP, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used